274 related articles for article (PubMed ID: 21805829)
21. Responder Definition of a Patient-Reported Outcome Instrument for Laryngopharyngeal Reflux Based on the US FDA Guidance.
Lien HC; Wang CC; Lee SW; Hsu JY; Yeh HZ; Ko CW; Chang CS; Liang WM
Value Health; 2015 Jun; 18(4):396-403. PubMed ID: 26091593
[TBL] [Abstract][Full Text] [Related]
22. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?
Spyridoulias A; Lillie S; Vyas A; Fowler SJ
Respir Med; 2015 Aug; 109(8):963-9. PubMed ID: 26044812
[TBL] [Abstract][Full Text] [Related]
23. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
24. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.
Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO
J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842
[TBL] [Abstract][Full Text] [Related]
25. An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease.
Semmanaselvan K; Mukaddam QI; Naik M
J Assoc Physicians India; 2015 Jul; 63(7):27-32. PubMed ID: 26731824
[TBL] [Abstract][Full Text] [Related]
26. Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.
Lam PK; Ng ML; Cheung TK; Wong BY; Tan VP; Fong DY; Wei WI; Wong BC
Clin Gastroenterol Hepatol; 2010 Sep; 8(9):770-6. PubMed ID: 20303417
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.
Yoon YH; Park KW; Lee SH; Park HS; Chang JW; Koo BS
Clin Otolaryngol; 2019 Jul; 44(4):612-618. PubMed ID: 31002475
[TBL] [Abstract][Full Text] [Related]
28. Combination of voice therapy and antireflux therapy rapidly recovers voice-related symptoms in laryngopharyngeal reflux patients.
Park JO; Shim MR; Hwang YS; Cho KJ; Joo YH; Cho JH; Nam IC; Kim MS; Sun DI
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):92-7. PubMed ID: 21908799
[TBL] [Abstract][Full Text] [Related]
29. [Study on the correlation between adenoid hypertrophy and laryngopharyngeal reflux in children].
Huang YD; Tan JJ; Han XY; Zeng FF; Li YF; Wang L; Li XP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(12):899-904. PubMed ID: 29921070
[No Abstract] [Full Text] [Related]
30. Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring.
Reichel O; Keller J; Rasp G; Hagedorn H; Berghaus A
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):205-10. PubMed ID: 17275540
[TBL] [Abstract][Full Text] [Related]
31. Effects of Proton Pump Inhibitor Therapy for Laryngopharyngeal Reflux on Posttreatment Symptoms and Hypopharyngeal pH.
Waxman J; Yalamanchali S; Valle ES; Pott T; Friedman M
Otolaryngol Head Neck Surg; 2014 Jun; 150(6):1010-7. PubMed ID: 24647643
[TBL] [Abstract][Full Text] [Related]
32. [Effect of different course of omeprazole in the treatment of laryngopharyngeal reflux].
Qi ZW; Lu HL; Zhang J; Zhang SJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):693-697. PubMed ID: 29771088
[No Abstract] [Full Text] [Related]
33. Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?
Vailati C; Mazzoleni G; Bondi S; Bussi M; Testoni PA; Passaretti S
J Voice; 2013 Jan; 27(1):84-9. PubMed ID: 23159026
[TBL] [Abstract][Full Text] [Related]
34. Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone.
Hunchaisri N
J Med Assoc Thai; 2012 Jan; 95(1):73-80. PubMed ID: 22379745
[TBL] [Abstract][Full Text] [Related]
35. Predictive Value of Laryngeal Mucosa Pepsin in Therapeutic Response of Laryngopharyngeal Reflux.
Liu CP; Jiang AY; Chen F; Wu J; Wang SY; Cao L; Liao T; Zheng YQ
J Voice; 2022 Jun; ():. PubMed ID: 35760633
[TBL] [Abstract][Full Text] [Related]
36. Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples.
Lechien JR; Bobin F; Muls V; Horoi M; Thill MP; Dequanter D; Finck C; Rodriguez A; Saussez S
Laryngoscope; 2021 Feb; 131(2):350-359. PubMed ID: 32510588
[TBL] [Abstract][Full Text] [Related]
37. Empiric esomeprazole in the treatment of laryngopharyngeal reflux.
DelGaudio JM; Waring JP
Laryngoscope; 2003 Apr; 113(4):598-601. PubMed ID: 12671413
[TBL] [Abstract][Full Text] [Related]
38. [The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux].
Luo H; Ma S; Gao Y; Yan J; Hou J; Xu M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(11):997-1001. PubMed ID: 26536702
[TBL] [Abstract][Full Text] [Related]
39. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
[TBL] [Abstract][Full Text] [Related]
40. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
Wu JC; Lai LH; Chow DK; Wong GL; Sung JJ; Chan FK
Neurogastroenterol Motil; 2011 Feb; 23(2):155-60, e31. PubMed ID: 21087355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
